The Department is considering carefully all available evidence around the potential of different medicines for use in treating COVID-19. Clinical trials are ongoing and being developed to assess the benefits of a number of different medicines in treating COVID-19.
Hydroxychloroquine is not currently licensed to treat COVID-19 related symptoms or prevent infection. Clinical trials are being established to test hydroxychloroquine as an agent in the treatment of COVID-19. These clinical trials are still not completed, so no conclusions have yet been reached on the safety and effectiveness of this medicine to treat or prevent COVID-19.